Lenzing's €600m Bet: Profits Are Rising, but Investors Are Still Demanding Proof
Published on 09/09/2026 at 18:02 | Editorial boerse-global.de
The arithmetic at Lenzing is becoming hard to ignore. Net profit more than doubled in the first half, the balance sheet is being fortified with hundreds of millions in fresh capital, and yet the share price keeps drifting lower — a disconnect that says as much about the scale of the company's restructuring as it does about market sentiment.
The Austrian fibre maker closed Tuesday's session at €22.60, down 1.3 percent on the day. Over the past month, the stock has shed 4.2 percent, leaving it roughly 24 percent below its 52-week high of €29.75. The equity now trades about 5.4 percent beneath its 50-day moving average of €23.88 and well under the 200-day line of €24.13, a technical picture that offers little comfort to holders. Market capitalisation stands at just under €877 million.
A Profitable Half, Overshadowed by What Comes Next
The underlying operational story, at least on paper, is one of genuine improvement. Lenzing reported net income of €35.6 million for the first six months of 2026, more than double the €15.2 million posted in the same period a year earlier. EBITDA reached €239.2 million on revenue of €1.27 billion, while free cash flow climbed to €45.8 million. Those figures, released on August 5, suggest the core business is holding up — for now.
The complication is that the second half of the year carries costs the first did not. Management has guided for impairments on long-term assets of up to €150 million for 2026, charges that will hit EBIT and group earnings while leaving EBITDA untouched. On top of that sit restructuring provisions for personnel measures of as much as €40 million, which will flow directly into this year's EBITDA. The half-year profit therefore reads less as a clean victory and more as evidence that operations can absorb the strain of transformation without collapsing — a modest but meaningful signal.
Shrinking to Grow: Plant Closures and 2,000 Job Cuts
The transformation in question, announced in late July under the banner "Grow Nonwovens, Reset Textiles," marks a decisive break with the past. The strategy calls for organic growth in the nonwovens business, a sharper focus on premium segments in textiles, and a strengthening of the pulp and biorefinery operations. The flip side is a sweeping consolidation of the production footprint: the Lyocell plant in Heiligenkreuz, Austria, will wind down by the end of this year, followed by the Grimsby facility in the UK by the end of 2027. Roughly 2,000 jobs are set to disappear group-wide by that point.
The market's reaction to the job-cut announcement was telling — the shares have lost around 3.4 percent since it was made roughly six weeks ago. CEO Georg Kasperkovitz has said he is seeking a new owner for the Heiligenkreuz site, noting that a sales process could "experience-wise" be concluded within a few months. Whether that softens the blow for the affected region or merely delays the inevitable remains an open question.
A €600m War Chest, With Strings Attached
To fund this ambitious pivot, Lenzing is assembling a financing package of up to €600 million. An extraordinary general meeting held just yesterday approved a capital increase of around €300 million, preserving statutory subscription rights for existing shareholders. That equity raise is to be matched by €300 million in new credit lines, with the company having already announced financing agreements of up to that amount in late July and extended maturities on existing debt to 2030. The capital increase must be executed no later than February 25, 2027.
The ownership structure has thrown its weight behind the plan. B&C Group, which holds 37.2 percent of the shares, and Brazilian pulp producer Suzano, with 15 percent, have both signalled their support — an important endorsement given that the capital raise will dilute existing holders. The market's muted response, however, suggests that institutional backing alone is not enough to dispel doubts about execution.
Restructuring of this scale brings inevitable operational disruption — and with plant closures and workforce reductions, workplace risk profiles change quickly. Keeping your safety documentation current through periods of transition is essential, and a free toolkit with 41 ready-to-use templates and checklists can help you stay on top of it without adding hours to your week. Download the free Risk Assessment Toolkit
Board Changes and a Share Price in the Doldrums
The same extraordinary general meeting brought a governance change: Martin Seiter has joined the supervisory board, succeeding Franz Gasselsberger, who stepped down at his own request. The timing is no coincidence — the company is simultaneously restructuring its capital base and its operations, and the new board member will have a front-row seat for both.
The share price has been a source of persistent disappointment. Over the past 30 days, the stock has lost 4.5 percent, and it remains down 2.8 percent since the start of the year. A brief moment of optimism came in June, when Kasperkovitz purchased 18,180 shares at €27.63 apiece, an investment of roughly €502,000 that was widely read as a vote of confidence. Around the same time, Berenberg upgraded the stock to "Buy" with a price target of €29.50, while ODDO BHF had earlier cut its target sharply to €20. Both calls are now several months old and reflect a market that has since moved on.
For Lenzing, the real test lies ahead. The capital increase provides financial headroom, and the half-year numbers demonstrate that the operating engine still works. But whether the promised margin improvement — management is targeting an EBITDA margin of 20 to 25 percent and an earnings uplift of €150 million — materialises in the coming quarters will determine whether this ambitious restructuring is remembered as a masterstroke or a miscalculation. The market, for now, is reserving judgment.
